These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 29544192)
1. Adult brain volume in multiple sclerosis: The impact of paediatric onset. Fenu G; Lorefice L; Loi L; Sechi V; Contu F; Coghe G; Frau J; Spinicci G; Barracciu MA; Marrosu MG; Cocco E Mult Scler Relat Disord; 2018 Apr; 21():103-107. PubMed ID: 29544192 [TBL] [Abstract][Full Text] [Related]
2. Association of Age at Onset With Gray Matter Volume and White Matter Microstructural Abnormalities in People With Multiple Sclerosis. Bonacchi R; Meani A; Pagani E; Marchesi O; Falini A; Filippi M; Rocca MA Neurology; 2021 Nov; 97(20):e2007-e2019. PubMed ID: 34607928 [TBL] [Abstract][Full Text] [Related]
3. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study. Galego O; Gouveia A; Batista S; Moura C; Machado E Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Yeh EA; Weinstock-Guttman B; Ramanathan M; Ramasamy DP; Willis L; Cox JL; Zivadinov R Brain; 2009 Dec; 132(Pt 12):3392-400. PubMed ID: 19892770 [TBL] [Abstract][Full Text] [Related]
5. Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans. Al-Kawaz M; Monohan E; Morris E; Perumal JS; Nealon N; Vartanian T; Gauthier SA J Neuroimaging; 2017 May; 27(3):333-338. PubMed ID: 27634620 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis. Kalinin I; Makshakov G; Evdoshenko E AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540 [TBL] [Abstract][Full Text] [Related]
7. Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls. Granberg T; Hashim F; Andersen O; Sundal C; Karrenbauer VD Eur J Neurol; 2016 Apr; 23(4):817-22. PubMed ID: 26756564 [TBL] [Abstract][Full Text] [Related]
8. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis. Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355 [TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy. Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718 [TBL] [Abstract][Full Text] [Related]
12. Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort. de Ruiter LRJ; Loonstra FC; Jelgerhuis JR; Coerver EME; Toorop AA; van Leeuwen ICE; Noteboom S; Moraal B; Strijbis EMM; Schoonheim MM; Uitdehaag BMJ Mult Scler Relat Disord; 2023 Mar; 71():104568. PubMed ID: 36805177 [TBL] [Abstract][Full Text] [Related]
13. The impact of deep grey matter volume on cognition in multiple sclerosis. Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200 [TBL] [Abstract][Full Text] [Related]
14. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis. Nourbakhsh B; Azevedo C; Maghzi AH; Spain R; Pelletier D; Waubant E J Neurol Sci; 2016 Jul; 366():229-233. PubMed ID: 27288812 [TBL] [Abstract][Full Text] [Related]
15. The role of global and regional gray matter volume decrease in multiple sclerosis. Grothe M; Lotze M; Langner S; Dressel A J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570 [TBL] [Abstract][Full Text] [Related]
16. Grey matter atrophy is associated with disability increase in natalizumab-treated patients. Ciampi E; Pareto D; Sastre-Garriga J; Vidal-Jordana A; Tur C; Río J; Tintoré M; Auger C; Rovira A; Montalban X Mult Scler; 2017 Apr; 23(4):556-566. PubMed ID: 27354019 [TBL] [Abstract][Full Text] [Related]
17. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis. Ruggieri S; Petracca M; Miller A; Krieger S; Ghassemi R; Bencosme Y; Riley C; Howard J; Lublin F; Inglese M JAMA Neurol; 2015 Dec; 72(12):1466-74. PubMed ID: 26457955 [TBL] [Abstract][Full Text] [Related]
18. Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression. Moccia M; Quarantelli M; Lanzillo R; Cocozza S; Carotenuto A; Carotenuto B; Alfano B; Prinster A; Triassi M; Nardone A; Palladino R; Brunetti A; Brescia Morra V Eur J Neurol; 2017 Jan; 24(1):195-204. PubMed ID: 27801535 [TBL] [Abstract][Full Text] [Related]
19. Whole brain and grey matter volume of Japanese patients with multiple sclerosis. Akaishi T; Nakashima I; Mugikura S; Aoki M; Fujihara K J Neuroimmunol; 2017 May; 306():68-75. PubMed ID: 28385190 [TBL] [Abstract][Full Text] [Related]